Format

Send to

Choose Destination
BMC Cancer. 2017 Aug 31;17(1):603. doi: 10.1186/s12885-017-3602-0.

Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China.

Author information

1
Department of Biostatistics, Public Health College, Harbin Medical University, 157 Baojian Road, Harbin, 150081, Heilongjiang, People's Republic of China.
2
People's Hospital of Jilin Province, Changchun, Jilin, People's Republic of China.
3
Department of Biostatistics, Public Health College, Harbin Medical University, 157 Baojian Road, Harbin, 150081, Heilongjiang, People's Republic of China. liumeina369@163.com.

Abstract

BACKGROUND:

Large gap exists between clinical practice and recommended care and large room exists for the improvement of care quality for non-small cell lung cancer (NSCLC) in China. Results of some studies have shown that assessment of care quality can help to make improvement and the development of quality indicators is deemed as the initial and most essential part. Yet there is no such an indicators system specifically suitable for Chinese health care system. The goal of the study is to set up a group of Chinese quality indicators for NSCLC care and make it the first step towards the improvement of NSCLC care quality in China.

METHODS:

We constructed a new indicator framework based on the characteristics of NSCLC care and the nature of Chinese health care system. Under the new framework, potential indicators were collected and a 3-round modified Delphi process was conducted by a national multi-disciplinary Expert Panel to develop a set of indicators until they reached the final consensus.

RESULTS:

A new indicator framework (structure, process, communication, management of symptoms or treatment toxicity and outcome) was developed. Seventy four indicators were extracted from guidelines and relevant literatures as potential indicators; 43 indicators plus 1 suggested indicator were remained after the discussion of Round 1; questionnaires of Round 2 were rated by Expert Panel and 19 indicators met the inclusion criteria and entered Round 3; 2 of the eliminated indicators in Round 2 were retrieved by the Expert Panel at the in-person meeting (Round 3). Therefore, 21 indicators got the final consensus of the Expert Panel.

CONCLUSIONS:

Guided by the new indicator structure, a set of indicators suitable for Chinese healthcare system was developed and can be utilized to measure and improve the care quality of non-small cell lung cancer.

KEYWORDS:

Chinese health system; Lung cancer; Quality indicators; Quality of care

PMID:
28859609
PMCID:
PMC5579936
DOI:
10.1186/s12885-017-3602-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center